Research Progress of Epigenetic Mechanism in Acquired Resistance of 
Targeted Therapy in Non-small Cell Lung Cancer

Research Progress of Epigenetic Mechanism in Acquired Resistance of 
Targeted Therapy in Non-small Cell Lung Cancer

Patients with oncogenic driver alterations of non-small cell lung cancer (NSCLC) can benefit from targeted therapy, but acquired resistance is inevitable ultimately. Epigenetic modifications, including DNA methylation, histone modifications, non-coding RNA-mediated regulate and chromatin remodeling,...

Full description

Bibliographic Details
Main Authors: Xin AI, Yan WANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2021-10-01
Series:Chinese Journal of Lung Cancer
Subjects:
lung neoplasms
targeted therapy
resistance mechanism
epigenomics
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.34

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.34

Similar Items